drugset / Trial / NCT03255330

The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma

NCT03255330

Phase 3 Withdrawn Masaryk University
RandomizedParallel-groupOpen-labelTreatment

Summary

Study of the effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma

Timeline

Start
2017-10
Primary completion
2020-02
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1800 mg
Comparator Tramadol Other / unclassified
Comparator dipyrone Unknown

Indications